ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,963Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 333

$605K Total Retail Price of All Prescriptions

Rank: 5 out of 333

388 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

74% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 1,951 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,198 203 S3 1 5
LISINOPRIL 658 102 2 1
GABAPENTIN 595 51 3 8
OMEPRAZOLE 293 60 4 3
PROAIR HFA 281 55 5 28
METHYLPREDNISOLONE 256 52 6 72
SIMVASTATIN 234 21 7 4
RANITIDINE HCL 230 42 8 22
TIZANIDINE HCL 227 26 9 33
MELOXICAM 206 29 10 25
ALENDRONATE SODIUM 185 50 11 41
CITALOPRAM HBR 178 27 12 23
ZOLPIDEM TARTRATE 168 32 13 50
METOPROLOL TARTRATE 160 11 14 10
SPIRIVA 159 28 15 36
FUROSEMIDE 155 15 16 7
NEXIUM 149 0 17 15
METOPROLOL SUCCINATE 145 34 18 14
AMLODIPINE BESYLATE 143 25 19 6
LEVOTHYROXINE SODIUM 142 25 20 2
SERTRALINE HCL 141 0 21 29
CYMBALTA 134 0 22 71
AZITHROMYCIN 132 43 23 24
ADVAIR DISKUS 131 28 24 38
IBUPROFEN 129 0 25 35
CRESTOR 128 0 26 20
METFORMIN HCL 124 33 27 9
CLOPIDOGREL 117 16 28 21
HYDROCHLOROTHIAZIDE 116 0 29 11
PROMETHAZINE HCL 114 0 R 30 55
SYMBICORT 112 12 31 88
ZETIA 99 0 32 52
POTASSIUM CHLORIDE 93 16 33 17
ATORVASTATIN CALCIUM 86 16 34 13
ATENOLOL 85 32 35 16
LOSARTAN POTASSIUM 83 18 36 26
VENTOLIN HFA 83 13 36 68
DIOVAN 77 0 38 67
TAMSULOSIN HCL 74 23 39 46
SUCRALFATE 73 0 40 133
LYRICA 71 0 41 81
PROMETHAZINE VC 70 26 R 42 202
CYCLOBENZAPRINE HCL 68 11 R 43 42
INSULIN SYRINGE 63 0 44 61
PLAVIX 61 0 45 32
LEVEMIR 60 0 46 139
DEXILANT 59 0 47 117
ROPINIROLE HCL 59 30 47 100
LANSOPRAZOLE 59 16 47 173
LOVAZA 57 0 50 54
PAROXETINE HCL 56 13 51 45
BUSPIRONE HCL 54 0 52 78
TRICOR 53 0 53 76
DULERA 53 15 53 234
FLUOXETINE HCL 53 0 53 49
THEOPHYLLINE ANHYDROUS 52 21 56 124
AVODART 50 17 57 247
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.